Product Information
POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0998 per EA under NDC 70010014701. Its NADAC has been published 251 times since Dec 15, 2021.
FDA first approved this application on Feb 16, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010014701
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214686FDA Approved
2/16/2021
TE Code
AB
On Market Since
3/1/2021
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 251 times since Dec 15, 2021, and over the history we have for it it has declined 58.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0998 per EA |
|---|---|
| All-time high | $0.2404 (Dec 15, 2021) |
| All-time low | $0.0914 (Jul 22, 2026) |
| 52-week high | $0.1336 |
| 52-week low | $0.0914 |
| Median price | $0.1436 |
| Average price | $0.1461 |
| Largest weekly change | -44.0% (Nov 23, 2022) |
| Weeks tracked | 251 |
| Tracking since | Dec 15, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.0998 per EA (NDC 70010014701), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 58.5%. It has been tracked across 251 weekly CMS publications since Dec 15, 2021.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?
Since Dec 15, 2021, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.0914 (Jul 22, 2026) to a high of $0.2404 (Dec 15, 2021), with a median of $0.1436 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?
POTASSIUM CL ER 8 MEQ CAPSULE (NDC 70010014701) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.